ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,165 Cr | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹2,165 Cr |
| Mar2024 | ₹1,796 Cr |
| Mar2023 | ₹984 Cr |
| Mar2022 | ₹1,646 Cr |
| Mar2021 | ₹1,585 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,165 Cr | 20.59 | |
| Mar2024 | ₹1,796 Cr | 82.47 | |
| Mar2023 | ₹984 Cr | -40.19 | |
| Mar2022 | ₹1,646 Cr | 3.82 | |
| Mar2021 | ₹1,585 Cr | - | |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹64,955.4 Cr | 1.2% | 0.1% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 1.2% |
0.1% |
11.5% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses